Pulmonary hypertension (pHTN) is a rare disease, with an estimated prevalence of 15-50 cases per million; however, the prevalence of pHTN in particular populations is substantially higher. Due to the progressive nature of the disease, the care and management of the pHTN patient is multifocal and requires a solid knowledge base of disease pathogenesis and pathophysiology. This continuing education activity is designed to provide an overview of the pathogenesis, pathophysiology and current treatment recommendations for pHTN.
You selected to get the course pHTN: What is pulmonary hype... (PULM005). Please Login to get it.